Objective: To determine whether prenatal ultrasound measurement of fetal stomach size, as a surrogate marker of fetal swallowing, is predictive of postnatal development of gastroesophageal reflux disease (GERD) in cases of isolated cleft lip and/or palate (CL/P). Design: This is a retrospective case–control study. The outcome of interest is postnatal diagnosis of GERD in isolated CL/P. The exposure of interest is prenatal stomach size measurement by ultrasound. Setting: The study population was selected from an academic, tertiary care center between 2003 and 2011. Patients/Participants: Cases were neonates undergoing CL/P repair during the study period. Cases with other known structural or chromosomal abnormalities were excluded. Controls were contemporary, nondiabetic neonates that matched gestational age (within one week) to cases. Each case measurement was matched ∼1:2 with control measurement. Interventions: None. Main Outcome Measure: The primary outcome was difference in mean prenatal ultrasound measurement of fetal stomach size between cases and controls. We hypothesized that patients with postnatal development of GERD would have smaller mean fetal stomach size. Results: There were 32 cases including 19 patients with unilateral cleft lip and palate, 8 with unilateral cleft lip, and 4 with bilateral cleft lip and palate. Cases were noted to have smaller mean anterior–posterior and transverse fetal stomach measurements as compared to controls. This was statistically significant from 16 to 21 weeks, 25 to 27 weeks, and 28 to 36 weeks ( P < .01 for all). Conclusions: Prenatal ultrasound measurement of fetal stomach size as a surrogate marker of fetal swallowing is predictive of postnatal development of GERD in isolated CL/P.
OBJECTIVE: To determine if the number of days in hospital postpartum after the diagnosis of preeclampsia with severe features is associated with postpartum readmission. STUDY DESIGN: This was a nested case control study of all patients with severe preeclampsia at an academic medical center from 2013 to 2017. The primary outcome was readmission within six weeks of discharge. The primary exposure was day of postpartum discharge in patients with preeclampsia with severe features. Controls were randomly selected from the patients who had been diagnosed with preeclampsia with severe features without readmission in a 2:1 ratio. ANOVA and logistic regression were utilized for comparisons. RESULTS: Of the 18,645 deliveries over this time period, 950 were complicated by preeclampsia with severe features. Of these deliveries, 39 were readmitted. The median gestational age on admission was 37 weeks and one day. Readmitted patients were more likely to be discharged earlier than those who were not readmitted (2 vs. 3 days, p¼0.039). This association was attenuated when mode of delivery was controlled for (aOR¼3.98, p¼0.046). CONCLUSION: Discharge three days after delivery in individuals diagnosed with preeclampsia with severe features is associated with fewer readmissions. Postpartum day of discharge was also an independent predictor of readmission when controlling for mode of delivery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.